We are live on ! Find out more
UROV

Urovant Sciences Ltd.
UROV

Delisted

UROV was delisted on the 26th of March, 2021.

Back to rankings

26 hedge funds and large institutions have $45.3M invested in Urovant Sciences Ltd. in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

24% less funds holding

Funds holding: 34 → 26 (-8)

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

47% less capital invested

Capital invested by funds: $86.3M → $45.3M (-$41M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
26
Holders Change
-8
Holders Change %
-23.53%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
7
Reduced
9
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
+$1.97M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.55M
3
PA
Perceptive Advisors
New York
+$1.48M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.21M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$840K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.21M
2
ACM
Asymmetry Capital Management
California
-$1.9M
3
Norges Bank
Norges Bank
Norway
-$1.5M
4
BlackRock
BlackRock
New York
-$1.36M
5
HI
HBK Investments
Texas
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
– -$2.21M -184,064 Closed
ACM
27
Asymmetry Capital Management
California
– -$1.9M -158,463 Closed
Norges Bank
28
Norges Bank
Norway
– -$1.5M -125,000 Closed
HI
29
HBK Investments
Texas
– -$1.33M -110,987 Closed
RSCM
30
Rock Springs Capital Management
Maryland
– -$1.2M -100,000 Closed
DIM
31
DC Investments Management
Virginia
– -$618K -51,502 Closed
WRF
32
Waddell & Reed Financial
Kansas
– -$420K -35,000 Closed
BCM
33
BlueCrest Capital Management
Jersey
– -$360K -30,000 Closed
MCM
34
Moore Capital Management
New York
– -$360K -30,000 Closed
OAC
35
OMERS Administration Corp
Ontario, Canada
– -$240K -20,000 Closed
LCM
36
Landscape Capital Management
New Jersey
– -$185K -15,435 Closed
PVI
37
Pura Vida Investments
New York
– -$120K -10,000 Closed
Tudor Investment Corp
38
Tudor Investment Corp
Connecticut
– -$120K -10,000 Closed
Victory Capital Management
39
Victory Capital Management
Texas
– -$60K -5,000 Closed
NMC
40
Nine Masts Capital
Hong Kong
– -$12K -1,000 Closed
CCA
41
Catalyst Capital Advisors
New York
– -$8K -700 Closed
Morgan Stanley
42
Morgan Stanley
New York
– +$573 +63 New
1
2

UROV Hedge Fund Activity: Q4 2018 in Review

26 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Urovant Sciences Ltd. (UROV) for Q4 2018, worth a combined $45.3M — down 47% from $86.3M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of UROV and 9 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 7 added.

The largest buyer was Sio Capital Management, adding an estimated $1.97M. The largest seller was Citadel Advisors, exiting entirely with an estimated $2.21M sold.

  • 26 institutional investors held Urovant Sciences Ltd. (UROV) as of Q4 2018, down from 34 in Q3 2018.
  • Funds reported $45.3M of Urovant Sciences Ltd. stock for Q4 2018, down 47% quarter-over-quarter.
  • 9 funds opened new Urovant Sciences Ltd. positions in Q4 2018 and 16 closed out, a net change of -7 holders.
  • The largest Urovant Sciences Ltd. buyer in Q4 2018 was Sio Capital Management, an estimated $1.97M added.
  • The largest Urovant Sciences Ltd. seller in Q4 2018 was Citadel Advisors, an estimated $2.21M sold.

Based on aggregated 13F filings for Q4 2018.